123 related articles for article (PubMed ID: 28585089)
1. Combination of cationic dexamethasone derivative and STAT3 inhibitor (WP1066) for aggressive melanoma: a strategy for repurposing a phase I clinical trial drug.
Sau S; Mondal SK; Kashaw SK; Iyer AK; Banerjee R
Mol Cell Biochem; 2017 Dec; 436(1-2):119-136. PubMed ID: 28585089
[TBL] [Abstract][Full Text] [Related]
2. Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.
Tang YJ; Sun ZL; Wu WG; Xing J; He YF; Xin DM; Han P
Genet Mol Res; 2015 Mar; 14(1):2450-60. PubMed ID: 25867391
[TBL] [Abstract][Full Text] [Related]
3. The tumor microenvironment expression of p-STAT3 influences the efficacy of cyclophosphamide with WP1066 in murine melanoma models.
Hatiboglu MA; Kong LY; Wei J; Wang Y; McEnery KA; Fuller GN; Qiao W; Davies MA; Priebe W; Heimberger AB
Int J Cancer; 2012 Jul; 131(1):8-17. PubMed ID: 21792892
[TBL] [Abstract][Full Text] [Related]
4. A novel phosphorylated STAT3 inhibitor enhances T cell cytotoxicity against melanoma through inhibition of regulatory T cells.
Kong LY; Wei J; Sharma AK; Barr J; Abou-Ghazal MK; Fokt I; Weinberg J; Rao G; Grimm E; Priebe W; Heimberger AB
Cancer Immunol Immunother; 2009 Jul; 58(7):1023-32. PubMed ID: 19002459
[TBL] [Abstract][Full Text] [Related]
5. The STAT3 inhibitor WP1066 synergizes with vorinostat to induce apoptosis of mantle cell lymphoma cells.
Lu K; Chen N; Zhou XX; Ge XL; Feng LL; Li PP; Li XY; Geng LY; Wang X
Biochem Biophys Res Commun; 2015 Aug; 464(1):292-8. PubMed ID: 26116769
[TBL] [Abstract][Full Text] [Related]
6. Sorafenib Sensitizes Glioma Cells to the BH3 Mimetic ABT-737 by Targeting MCL1 in a STAT3-Dependent Manner.
Kiprianova I; Remy J; Milosch N; Mohrenz IV; Seifert V; Aigner A; Kögel D
Neoplasia; 2015 Jul; 17(7):564-73. PubMed ID: 26297434
[TBL] [Abstract][Full Text] [Related]
7. The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6.
Lu K; Fang XS; Feng LL; Jiang YJ; Zhou XX; Liu X; Li PP; Chen N; Ding M; Wang N; Zhang J; Wang X
Cancer Lett; 2015 Apr; 359(2):250-8. PubMed ID: 25636517
[TBL] [Abstract][Full Text] [Related]
8. STAT3 inhibitor WP1066 attenuates miRNA-21 to suppress human oral squamous cell carcinoma growth in vitro and in vivo.
Zhou X; Ren Y; Liu A; Han L; Zhang K; Li S; Li P; Li P; Kang C; Wang X; Zhang L
Oncol Rep; 2014 May; 31(5):2173-80. PubMed ID: 24676554
[TBL] [Abstract][Full Text] [Related]
9. A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo.
Iwamaru A; Szymanski S; Iwado E; Aoki H; Yokoyama T; Fokt I; Hess K; Conrad C; Madden T; Sawaya R; Kondo S; Priebe W; Kondo Y
Oncogene; 2007 Apr; 26(17):2435-44. PubMed ID: 17043651
[TBL] [Abstract][Full Text] [Related]
10. A novel inhibitor of signal transducers and activators of transcription 3 activation is efficacious against established central nervous system melanoma and inhibits regulatory T cells.
Kong LY; Abou-Ghazal MK; Wei J; Chakraborty A; Sun W; Qiao W; Fuller GN; Fokt I; Grimm EA; Schmittling RJ; Archer GE; Sampson JH; Priebe W; Heimberger AB
Clin Cancer Res; 2008 Sep; 14(18):5759-68. PubMed ID: 18794085
[TBL] [Abstract][Full Text] [Related]
11. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis.
Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L
Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838
[TBL] [Abstract][Full Text] [Related]
12. STAT3 inhibitor WP1066 as a novel therapeutic agent for bCCI neuropathic pain rats.
Xue ZJ; Shen L; Wang ZY; Hui SY; Huang YG; Ma C
Brain Res; 2014 Oct; 1583():79-88. PubMed ID: 25084036
[TBL] [Abstract][Full Text] [Related]
13. Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells.
Chiu HC; Chou DL; Huang CT; Lin WH; Lien TW; Yen KJ; Hsu JT
Biochem Pharmacol; 2011 Jun; 81(11):1263-70. PubMed ID: 21406185
[TBL] [Abstract][Full Text] [Related]
14. Cationic lipid-conjugated dexamethasone as a selective antitumor agent.
Sau S; Banerjee R
Eur J Med Chem; 2014 Aug; 83():433-47. PubMed ID: 24992071
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of gp130-mediated tyrosine phosphorylation of STAT3 and its DNA-binding activity in dexamethasone-treated AIDS-associated Kaposi's sarcoma cells: selective synergy between dexamethasone and gp130-related growth factors in Kaposi's sarcoma cell proliferation.
Murakami-Mori K; Mori S; Taga T; Kishimoto T; Nakamura S
J Immunol; 1997 Jun; 158(11):5518-26. PubMed ID: 9164976
[TBL] [Abstract][Full Text] [Related]
16. Delayed Administration of WP1066, an STAT3 Inhibitor, Ameliorates Radiation-Induced Lung Injury in Mice.
Yu J; Yuan X; Liu Y; Zhang K; Wang J; Zhang H; Liu F
Lung; 2016 Feb; 194(1):67-74. PubMed ID: 26563331
[TBL] [Abstract][Full Text] [Related]
17. STAT3 inhibition by WP1066 suppresses the growth and invasiveness of bladder cancer cells.
Tsujita Y; Horiguchi A; Tasaki S; Isono M; Asano T; Ito K; Asano T; Mayumi Y; Kushibiki T
Oncol Rep; 2017 Oct; 38(4):2197-2204. PubMed ID: 28849140
[TBL] [Abstract][Full Text] [Related]
18. Troxerutin (TXN) potentiated 5-Fluorouracil (5-Fu) treatment of human gastric cancer through suppressing STAT3/NF-κB and Bcl-2 signaling pathways.
Xu GY; Tang XJ
Biomed Pharmacother; 2017 Aug; 92():95-107. PubMed ID: 28531805
[TBL] [Abstract][Full Text] [Related]
19. Development of new estradiol-cationic lipid hybrids: ten-carbon twin chain cationic lipid is a more suitable partner for estradiol to elicit better anticancer activity.
Sudhakar G; Bathula SR; Banerjee R
Eur J Med Chem; 2014 Oct; 86():653-63. PubMed ID: 25222876
[TBL] [Abstract][Full Text] [Related]
20. B cell translocation gene 2 (Btg2) is regulated by Stat3 signaling and inhibits adipocyte differentiation.
Kim S; Hong JW; Park KW
Mol Cell Biochem; 2016 Feb; 413(1-2):145-53. PubMed ID: 26738493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
